N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide

C104H121F3N26O25 — CID 165093190

IUPACN-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide
SMILESCN1C[C@@H](NC(=O)COc2ccccc2)C[C@H]1c1nc(-c2ccc3c(c2)OCO3)no1.CN1C[C@@H](NC(=O)COc2ccccc2)C[C@H]1c1nc(-c2cccnc2)no1.COC(=O)COCC(=O)N[C@H]1C[C@@H](c2nc(-c3cccnc3)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(-c3ccc(OC(F)(F)F)cc3)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(-c3ccc4c(c3)OCO4)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(C)no2)N(C)C1
InChIInChI=1S/C22H22N4O5.C20H21N5O3.C17H19F3N4O4.C17H21N5O5.C17H20N4O5.C11H18N4O3/c1-26-11-15(23-20(27)12-28-16-5-3-2-4-6-16)10-17(26)22-24-21(25-31-22)14-7-8-18-19(9-14)30-13-29-18;1-25-12-15(22-18(26)13-27-16-7-3-2-4-8-16)10-17(25)20-23-19(24-28-20)14-6-5-9-21-11-14;1-24-8-11(21-14(25)9-26-2)7-13(24)16-22-15(23-28-16)10-3-5-12(6-4-10)27-17(18,19)20;1-22-8-12(19-14(23)9-26-10-15(24)25-2)6-13(22)17-20-16(21-27-17)11-4-3-5-18-7-11;1-21-7-11(18-15(22)8-23-2)6-12(21)17-19-16(20-26-17)10-3-4-13-14(5-10)25-9-24-13;1-7-12-11(18-14-7)9-4-8(5-15(9)2)13-10(16)6-17-3/h2-9,15,17H,10-13H2,1H3,(H,23,27);2-9,11,15,17H,10,12-13H2,1H3,(H,22,26);3-6,11,13H,7-9H2,1-2H3,(H,21,25);3-5,7,12-13H,6,8-10H2,1-2H3,(H,19,23);3-5,11-12H,6-9H2,1-2H3,(H,18,22);8-9H,4-6H2,1-3H3,(H,13,16)/t2*15-,17-;11-,13-;12-,13-;11-,12-;8-,9-/m000000/s1
InChIKeyXBHUVAVBGJAZDY-KDAOTBNASA-N
MW2192.26 g/mol
LogP7.66
Rot. Bonds34

About N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide

N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide (PubChem CID 165093190) has the molecular formula C104H121F3N26O25 and a molecular weight of 2192.26 g/mol. Its IUPAC name is N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide.

Molecular Properties

Compound NameN-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide
PubChem CID165093190
Molecular FormulaC104H121F3N26O25
Molecular Weight2192.26 g/mol
Exact Mass2190.89
IUPAC NameN-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide
SMILESCN1C[C@@H](NC(=O)COc2ccccc2)C[C@H]1c1nc(-c2ccc3c(c2)OCO3)no1.CN1C[C@@H](NC(=O)COc2ccccc2)C[C@H]1c1nc(-c2cccnc2)no1.COC(=O)COCC(=O)N[C@H]1C[C@@H](c2nc(-c3cccnc3)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(-c3ccc(OC(F)(F)F)cc3)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(-c3ccc4c(c3)OCO4)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(C)no2)N(C)C1
InChIInChI=1S/C22H22N4O5.C20H21N5O3.C17H19F3N4O4.C17H21N5O5.C17H20N4O5.C11H18N4O3/c1-26-11-15(23-20(27)12-28-16-5-3-2-4-6-16)10-17(26)22-24-21(25-31-22)14-7-8-18-19(9-14)30-13-29-18;1-25-12-15(22-18(26)13-27-16-7-3-2-4-8-16)10-17(25)20-23-19(24-28-20)14-6-5-9-21-11-14;1-24-8-11(21-14(25)9-26-2)7-13(24)16-22-15(23-28-16)10-3-5-12(6-4-10)27-17(18,19)20;1-22-8-12(19-14(23)9-26-10-15(24)25-2)6-13(22)17-20-16(21-27-17)11-4-3-5-18-7-11;1-21-7-11(18-15(22)8-23-2)6-12(21)17-19-16(20-26-17)10-3-4-13-14(5-10)25-9-24-13;1-7-12-11(18-14-7)9-4-8(5-15(9)2)13-10(16)6-17-3/h2-9,15,17H,10-13H2,1H3,(H,23,27);2-9,11,15,17H,10,12-13H2,1H3,(H,22,26);3-6,11,13H,7-9H2,1-2H3,(H,21,25);3-5,7,12-13H,6,8-10H2,1-2H3,(H,19,23);3-5,11-12H,6-9H2,1-2H3,(H,18,22);8-9H,4-6H2,1-3H3,(H,13,16)/t2*15-,17-;11-,13-;12-,13-;11-,12-;8-,9-/m000000/s1
InChIKeyXBHUVAVBGJAZDY-KDAOTBNASA-N
XLogP7.66
TPSA581.17 Ų
H-Bond Donors6
H-Bond Acceptors45
Rotatable Bonds34
Heavy Atoms158
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002192.26
LogP ≤ 57.66
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1045

Analyze N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide?
The IUPAC name of N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide (CID 165093190) is N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide.
What is the SMILES notation for N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide?
The canonical SMILES for N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide is CN1C[C@@H](NC(=O)COc2ccccc2)C[C@H]1c1nc(-c2ccc3c(c2)OCO3)no1.CN1C[C@@H](NC(=O)COc2ccccc2)C[C@H]1c1nc(-c2cccnc2)no1.COC(=O)COCC(=O)N[C@H]1C[C@@H](c2nc(-c3cccnc3)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(-c3ccc(OC(F)(F)F)cc3)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(-c3ccc4c(c3)OCO4)no2)N(C)C1.COCC(=O)N[C@H]1C[C@@H](c2nc(C)no2)N(C)C1.
What is the InChIKey of N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide?
The InChIKey is XBHUVAVBGJAZDY-KDAOTBNASA-N. The full InChI is InChI=1S/C22H22N4O5.C20H21N5O3.C17H19F3N4O4.C17H21N5O5.C17H20N4O5.C11H18N4O3/c1-26-11-15(23-20(27)12-28-16-5-3-2-4-6-16)10-17(26)22-24-21(25-31-22)14-7-8-18-19(9-14)30-13-29-18;1-25-12-15(22-18(26)13-27-16-7-3-2-4-8-16)10-17(25)20-23-19(24-28-20)14-6-5-9-21-11-14;1-24-8-11(21-14(25)9-26-2)7-13(24)16-22-15(23-28-16)10-3-5-12(6-4-10)27-17(18,19)20;1-22-8-12(19-14(23)9-26-10-15(24)25-2)6-13(22)17-20-16(21-27-17)11-4-3-5-18-7-11;1-21-7-11(18-15(22)8-23-2)6-12(21)17-19-16(20-26-17)10-3-4-13-14(5-10)25-9-24-13;1-7-12-11(18-14-7)9-4-8(5-15(9)2)13-10(16)6-17-3/h2-9,15,17H,10-13H2,1H3,(H,23,27);2-9,11,15,17H,10,12-13H2,1H3,(H,22,26);3-6,11,13H,7-9H2,1-2H3,(H,21,25);3-5,7,12-13H,6,8-10H2,1-2H3,(H,19,23);3-5,11-12H,6-9H2,1-2H3,(H,18,22);8-9H,4-6H2,1-3H3,(H,13,16)/t2*15-,17-;11-,13-;12-,13-;11-,12-;8-,9-/m000000/s1.
What are the key properties of N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide?
N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide has a molecular weight of 2192.26 g/mol, XLogP of 7.66, 34 rotatable bonds, 6 hydrogen bond donors, and 45 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-methoxyacetamide;N-[(3S,5S)-5-[3-(1,3-benzodioxol-5-yl)-1,2,4-oxadiazol-5-yl]-1-methylpyrrolidin-3-yl]-2-phenoxyacetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-(3-methyl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]acetamide;2-methoxy-N-[(3S,5S)-1-methyl-5-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]pyrrolidin-3-yl]acetamide;methyl 2-[2-[[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]amino]-2-oxoethoxy]acetate;N-[(3S,5S)-1-methyl-5-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl]-2-phenoxyacetamide is sourced from PubChem (CID 165093190), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).